| Identification | Back Directory | [Name]
[(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl] (E)-3-[4-[2-(dimethylamino)ethoxy]phenyl]prop-2-enoate,oxalic acid | [CAS]
529511-79-3 | [Synonyms]
ZGN-433)
Beloranib hemioxalate
Beloranib hemioxalate
(CKD-732
[(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl] (E)-3-[4-[2-(dimethylamino)ethoxy]phenyl]prop-2-enoate,oxalic acid | [Molecular Formula]
C31H43NO10 | [MDL Number]
MFCD28902303 | [MOL File]
529511-79-3.mol | [Molecular Weight]
589.68 |
| Hazard Information | Back Directory | [Uses]
Beloranib Hemioxalate is the acidic form of beloranib (B131280), which is a pharmaceutical drug that is currently being evaluated through biological studies for its potential to combat obesity. |
|
|